Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China

Lancet
Hua WangYu Wang

Abstract

In December, 2007, a family cluster of two individuals infected with highly pathogenic avian influenza A (H5N1) virus was identified in Jiangsu Province, China. Field and laboratory investigations were implemented immediately by public-health authorities. Epidemiological, clinical, and virological data were collected and analysed. Respiratory specimens from the patients were tested by reverse transcriptase (RT) PCR and by viral culture for the presence of H5N1 virus. Contacts of cases were monitored for symptoms of illness for 10 days. Any contacts who became ill had respiratory specimens collected for H5N1 testing by RT PCR. Sera were obtained from contacts for H5N1 serological testing by microneutralisation and horse red-blood-cell haemagglutinin inhibition assays. The 24-year-old index case died, and the second case, his 52-year-old father, survived after receiving early antiviral treatment and post-vaccination plasma from a participant in an H5N1 vaccine trial. The index case's only plausible exposure to H5N1 virus was a poultry market visit 6 days before the onset of illness. The second case had substantial unprotected close exposure to his ill son. 91 contacts with close exposure to one or both cases without adequate prot...Continue Reading

Associated Clinical Trials

References

Jul 9, 1999·The Journal of Infectious Diseases·A W MountsK Fukuda
Feb 28, 2004·Lancet·J S M PeirisY Guan
Jan 26, 2005·The New England Journal of Medicine·Kumnuan UngchusakSupamit Chunsutthiwat
Mar 9, 2005·Emerging Infectious Diseases·Nguyen Thanh LiemUNKNOWN World Health Organization International Avian Influenza Investigation Team, Vietnam
Jan 21, 2006·Emerging Infectious Diseases·Sonja J OlsenSupamit Chunsuttiwat
Oct 5, 2007·The New England Journal of Medicine·Boping ZhouYi Guan

❮ Previous
Next ❯

Citations

Aug 31, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L XieX-P Xu
Aug 18, 2012·Virologica Sinica·Jianjun Chen
Nov 1, 2013·The Journal of Microbiology·Byeong-Jae LeeYoung Ki Choi
Jun 6, 2013·Virus Research·Guus F Rimmelzwaan, Jacqueline M Katz
Aug 21, 2013·Virus Research·M ImaiY Kawaoka
Aug 16, 2011·Prehospital and Disaster Medicine·Satoko MitaniYoshiyuki Watanabe
Nov 4, 2009·Cell Research·Gabriele NeumannYoshihiro Kawaoka
Dec 25, 2009·The New England Journal of Medicine·Timothy M UyekiJohn A Branda
May 7, 2009·The Journal of Infectious Diseases·Lei ZhouHongjie Yu
Mar 29, 2012·The Journal of Infectious Diseases·Sander HerfstRon A M Fouchier
Mar 20, 2010·The Journal of Antimicrobial Chemotherapy·James R Smith
Aug 19, 2009·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Ying MaGeorge F Gao
Jun 23, 2012·Science·Sander HerfstRon A M Fouchier
Aug 5, 2011·Clinical and Vaccine Immunology : CVI·T V ChirkovaL G Rudenko
Mar 1, 2012·MBio·Michael T Osterholm, Nicholas S Kelley
Jan 12, 2010·Annual Review of Medicine·Suryaprakash Sambhara, Gregory A Poland
Jan 6, 2011·The Journal of Clinical Investigation·Donna M Tscherne, Adolfo García-Sastre
Jun 26, 2009·PLoS Medicine·Nicholas J WhiteTimothy M Uyeki
Jan 13, 2012·PloS One·Tjandra Y AditamaI Nyoman Kandun
Oct 3, 2013·PloS One·David A ShoreJames Stevens
Apr 29, 2014·PloS One·Zhibin PengHongjie Yu
Oct 8, 2009·American Journal of Public Health·Scott SantibañezStephen Redd
Nov 26, 2009·Uirusu·Takeshi Ichinohe, Akiko Iwasaki
Nov 4, 2008·Emerging Infectious Diseases·Yang HuaiHongjie Yu
Jul 1, 2010·Emerging Infectious Diseases·Amr KandeelNasr El-Sayed
Oct 30, 2010·Emerging Infectious Diseases·Ji ZhangZhan Li
Nov 22, 2012·Viruses·Carolien E van de SandtGuus F Rimmelzwaan
Oct 1, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E J A SchrauwenR A M Fouchier
Feb 1, 2014·Emerging Microbes & Infections·Eefje Ja Schrauwen, Ron Am Fouchier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The New England Journal of Medicine
I Nyoman KandunTimothy M Uyeki
The New England Journal of Medicine
Kumnuan UngchusakSupamit Chunsutthiwat
The New England Journal of Medicine
Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian InfTimothy M Uyeki
© 2022 Meta ULC. All rights reserved